| Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM-Could combination therapy checkmate the collusion? SD Precilla, I Biswas, SS Kuduvalli, TS Anitha Cellular Signalling 95, 110350, 2022 | 21 | 2022 |
| Disentangling the therapeutic tactics in GBM: From bench to bedside and beyond S Daisy Precilla, SS Kuduvalli, ... Cell Biology International 45 (1), 18-53, 2021 | 12 | 2021 |
| Integration of synthetic and natural derivatives revives the therapeutic potential of temozolomide against glioma-an in vitro and in vivo perspective SD Precilla, SS Kuduvalli, EA Praveena, S Thangavel, TS Anitha Life Sciences 301, 120609, 2022 | 8 | 2022 |
| Can artificial intelligence overtake human intelligence on the bumpy road towards glioma therapy? PS Daisy, TS Anitha Medical Oncology 38, 1-11, 2021 | 8 | 2021 |
| Wnt/β-catenin antagonists: Exploring new avenues to trigger old drugs in alleviating glioblastoma multiforme DS Precilla, SS Kuduvalli, M Purushothaman, P Marimuthu, ... Current Molecular Pharmacology 15 (2), 338-360, 2022 | 7 | 2022 |
| Synergism of temozolomide, metformin, and epigallocatechin gallate promotes oxidative stress-induced apoptosis in glioma cells SS Kuduvalli, DS Precilla, V Anandhan, AT Sivasubramanian Current Drug Therapy 16 (3), 252-267, 2021 | 7 | 2021 |
| Will CRISPR-Cas9 have cards to play against cancer? An update on its applications PS Daisy, KS Shreyas, TS Anitha Molecular Biotechnology 63 (2), 93-108, 2021 | 7 | 2021 |
| A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo SS Kuduvalli, PS Daisy, A Vaithy, M Purushothaman, ... Frontiers in pharmacology 14, 1096614, 2023 | 5 | 2023 |
| Evaluation of cell doubling time in C6 and Y79 cell lines based on seeding density SS Kuduvalli, O Ramalakshmi, S Daisy Precilla, TS Anitha J Basic Clin Appl Health Sci 2 (4), 146-149, 2019 | 4 | 2019 |
| Repurposing synthetic and natural derivatives induces apoptosis in an orthotopic glioma‐induced xenograft model by modulating WNT/β‐catenin signaling S Daisy Precilla, SS Kuduvalli, I Biswas, K Bhavani, AB Pillai, JM Thomas, ... Fundamental & Clinical Pharmacology 37 (6), 1179-1197, 2023 | 2 | 2023 |
| Unveiling the anti-glioma potential of a marine derivative, Fucoidan: its synergistic cytotoxicity with Temozolomide—an in vitro and in silico experimental study I Biswas, DS Precilla, SS Kuduvalli, MA Ramachandran, S Akshaya, ... 3 Biotech 13 (12), 397, 2023 | 1 | 2023 |
| Synthesis of biocomposites from microalgal peptide incorporated polycaprolactone/κ-carrageenan nanofibers and their antibacterial and wound healing property S Raghunathan, S Kandasamy, AB Pillai, DP Senthilathiban, N Thajuddin, ... International Journal of Pharmaceutics 655, 124052, 2024 | | 2024 |
| Corrigendum: A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo SS Kuduvalli, PS Daisy, A Vaithy, M Purushothaman, AR Muralidharan, ... Frontiers in Pharmacology 14, 1322332, 2024 | | 2024 |
| A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo(vol 14, 1322332, 2024) SS Kuduvalli, PS Daisy, A Vaithy, M Purushothaman, AR Muralidharan, ... FRONTIERS IN PHARMACOLOGY 14, 2024 | | 2024 |
| A Dynamic Disease Model Portraying the Challenges and Management of COVID-19 in Puducherry, India: A Narrative Review DS Precilla, SS Kuduvallli, BA Kumar, SR Rao, TS Anitha Annals of SBV 11 (2), 45-54, 2022 | | 2022 |
| The synergistic anti-Warburg efficacy of temozolomide, metformin and epigallocatechin gallate in glioblastoma SS Kuduvalli, DS Precilla, I Biswas, TS Anitha bioRxiv, 2022.11. 22.517597, 2022 | | 2022 |
